Morning Overview on MSN
A new gene-editing treatment just drove back advanced stomach and colon cancers in an early trial — by reprogramming patients’ own immune cells to hunt the tumors
Twelve people whose stomach or colon cancers had defeated every available treatment were infused with their own immune cells, ...
The FDA has approved datopotamab deruxtecan (Dato-DXd, Datroway, Daiichi Sankyo) for the treatment of patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results